Insights on the Veterinary Dermatology Drugs Global Market to 2027 - by Route of | User Walls

The Global Veterinary Dermatology Drugs Market By Route of Administration, By Distribution Channel, By Drug Indication, By Animal Type, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 report has been added to ResearchAndMarkets.com's offering.

The global veterinary dermatology drugs market size is expected to reach $13.6 billion by 2027, rising at a market growth of 8.2% CAGR during the forecast period.

Key Market Players:

• Merck Group
• Elanco Animal Health, Inc.
• Zoetis, Inc.
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Vetoquinol SA (Soparfin SCA)
• Virbac
• Bioiberica, S.A.U.
• Bimeda, Inc.
• Ceva Sante Animale

Veterinary dermatologists are well qualified in diagnosing and providing solutions for different infectious skin diseases like fungal, bacterial, and viral in animals. The majority of animals globally are affected by major diseases such as parasitic skin diseases, alopecia, dander-related skin disorders, intrinsic skin infections, mild and harmful skin cancer, autoimmune skin diseases hormonal-related skin diseases, and other internal causes for skin abnormalities.

Moreover, constant development in medical equipment and surge in research sources for veterinary dermatologists to diagnose and treat these major diseases is crucial for pets, pet owners, and other animals. Therefore, the growth of the veterinary dermatology drugs market is expected to witness bright growth prospects due to the increasing number of veterinary visits.